Stephen Litt has been conducting science experiments since he was in first grade. Every year, the projects became more and more complicated — until finally, as a 7th grader, he came across something that gained national attention.
The 12-year-old boy from Marietta, Georgia, discovered evidence that chemicals in green tea may have cancer-fighting potential.
For this year’s science fair project, he tested epigallocatechin-3-gallate (EGCG), an antioxidant in green tea, to determine whether it could prevent breast cancer tumors in planaria, a type of flatworms.
The research, which was part of his award-winning project for the Georgia Science and Engineering Fair, earned the boy praise from scientists across the country.
He was even invited to go on a private tour of the Allen Discovery Center at Tufts University while on spring break in Boston two weeks ago.
“It’s not a cure for cancer,” his father, Lesley Litt, who trained as a chemist and assisted with the project, told CBS News. “What he found is a way to prevent cancer in these worms from those specific carcinogens. Their DNA is not the same as humans, but a professor at Tufts and a few others, they want to know what’s going on — they want to help.”
Stephen was originally interested in researching the malaria virus after reading about it in class back in October.
“I said, ‘Uh, no, we can’t bring that stuff into the house — it’s dangerous,’” his father said.
Around that time, two close family friends were diagnosed with breast cancer. That’s when Stephen shifted his focus.
“He started reading about cancer, specifically breast cancer,” Litt explained. “He found an article about how the Japanese might have lower cancer rates because of green tea. He then read an article in Live Science about green tea’s anti-cancer secrets.”
The article noted that in Japan, where green tea consumption is high, prostate and breast cancer rates are about three times lower when compared with the United States, according to the World Health Organization, although many other factors may play a role.
Is there really a connection between green tea and fighting cancer? Stephen had to find out.
So the boy, with help from his father, set up a lab in his house. Stephen ordered 100 planaria, which he divided into 4 groups. Each group was exposed to a different substance over the course of four weeks.
One group was exposed to EGCG; the second group was exposed to EGCG for 24 hours and then two carcinogens (Stephen’s dad handled the hazardous stuff); the third group was exposed to the two types of carcinogens; and the fourth — as a control group — was only exposed to spring water.
Carefully, Stephen studied the changes the worms experienced, documenting every tumor grown over the month-long period.
By the end of the experiment, Stephen determined that the worms exposed to EGCG and carcinogens didn’t grow any tumors, proving the antioxidant may actually help fight cancer growth in worm cells.
“We’re very far off from finding a cure for humans,” Litt clarified. “But this really does advance the research and give us more insight into what’s going on with human cancer cells.”
While it’s a good start, Litt says his son’s study is just beginning.
Next year, he’s hoping to get a better microscope and hopes to transplant real breast cancer tissue into these worms.
“He could use another year or two, hopefully at a unviersity lab,” said Litt, explaining that his future research will become more complicated.
In the mean time, Stephen has plenty to keep him busy. Not only is he a straight-A student, he’s a Boy Scout, working on becoming a black belt in karate, he plays tennis, and he’s one of the top oboe players in the state.
“Sometimes he even has time to play on his computer,” Litt said.
His parents couldn’t be more proud of the aspiring chemical engineer, especially with his most recent science experiment.
“He got results, which you don’t always get,” Litt said.
Whether you or a loved one is searching for hair loss solutions, lymphedema chronic swelling solutions, or mastectomy solutions, Ricky Knowles Hair and Wellness is here to help you rediscover confidence. A husband and wife team with over 40 years of combined specialized training, we offer our clients exclusive access to the latest advances in mastectomy, hair loss and lymphedema products and services.
Showing posts with label cancer research. Show all posts
Showing posts with label cancer research. Show all posts
Monday, April 17, 2017
Thursday, December 22, 2016
Cancer-stricken 'Jeopardy!' player wins $103K before death
![]() |
| photo provided by Jeopardy Productions Inc. |
She made the most of it by winning six nights in a row and more than $103,000 in a run that ended on Wednesday's episode. The Austin, Texas, woman died Dec. 5 at the age of 41, eight days before her first appearance aired on Dec. 13. "Jeopardy!" sent her advance copies of three of her appearances so she could watch them in the hospital, the show said in a statement .
It also expedited getting her winnings to her. Before her August audition for the show, Stowell emailed a "Jeopardy!" producer that she didn't have long to live and that if she were selected she'd like to donate any winnings to charities involved in cancer research. She passed the audition and was booked for the first available taping on Aug. 31, "Jeopardy!" said. She won four games taped that day and returned for a Sept. 13 taping. She won two more games before finishing second in her final appearance. Alex Trebek paid tribute to Stowell on Wednesday's program.
The "Jeopardy!" host called her appearance "a fulfillment of a lifelong ambition." The show's executive producer, Harry Friedman, added in a statement: "Cindy came on the show with a mission. We gave her the opportunity to fulfill that mission and she made the most of it." In a video released by the show Wednesday night, Stowell called her appearance "a line in the sand" that she drew in her battle against the disease. "I'm dying of cancer," she said. "I really want the money that I win to be used to help others and so this seems like a good opportunity."
The Cancer Research Institute tweeted its thanks to Stowell on Wednesday for donating winnings and inspiring others to do the same. Stowell came from behind to win several times during her run, which she said made the experience stressful, yet fun. "Even when you think the odds are completely against you somehow you know, via luck or something, things can work out."
Labels:
cancer research,
colon cancer,
jeopardy contestant
Location:
Houston, TX, USA
Thursday, September 8, 2016
'Cancer Moonshot' Panel: Focus on Immune Therapies
Cancer research should focus on getting more tailored data from individual patients — and provide that information to them and their doctors in a useful way, experts said Wednesday.
And because a new approach called immunotherapy seems to work so spectacularly for some patients, researchers and doctors should create networks to focus on that approach, a panel of cancer experts working on the Obama administration's "cancer moonshot" initiative said in a new report. Immunotherapies include techniques that manipulate the body's own immune defenses against tumor cells, including direct changes to patient's individual cells, drugs that boost immune activity and engineered antibodies trained to recognize particular tumors.
They include the new class of drugs that appear to have made former President Jimmy Carter's melanoma disappear, such as Keytruda and Opdivo, which block the mechanisms that tumors use to hide from immune cells. "Immunotherapy is important. We need to understand it better," said Dr. Douglas Lowy, acting director of the National Cancer Institute. "It is an extremely exciting area of medicine and science today but even now it only benefits a subset of patients," added Tyler Jacks, director of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology and a panel co-chair. "We must learn why some patients who have melanoma (such as President Carter) or lung cancer respond to checkpoint blockade immunotherapy, whereas patients with many other types of adult cancers, including ovarian, breast, pancreatic, brain, and prostate cancer—as well as most pediatric cancers—have brief responses or do not respond at all," the report reads.
"Current immunotherapy treatments represent only the tip of the iceberg of what is possible," it adds. The report repeats much of what's already been said about the "Cancer Moonshot," spearheaded by Vice President Joe Biden and vulnerable to the funding decisions of a deadlocked and partisan Congress. It focuses on 10 areas that might help the program achieve its goal of making 10 years worth of progress in half that time. There's also a new approach to the old-fashioned bone marrow stem cell transplant. Called chimeric antigen receptor T-cell, or CAR-T, these treatments use a patient's own immune system T-cells, engineered to better recognize cancer cells.
But they require destruction of the patient's existing immune system and that can kill the patient before it cures. One of the main changes proposed by the panel would be to offer tailored tumor profiling to more cancer patients. Right now, patients usually need to be treated at a big cancer center and take part in a major clinical trial to get an individual genetic sequence done. The panel's report proposes offering this service to cancer patients everywhere. "Many patients are eager to provide their data, and gathering this information in a linked network of databases would enable more precise knowledge about what works, in whom, and in which types of cancer," the report reads. And this data could help researchers with a third goal -- creating a big, 3-D atlas of cancer.
It ideally would show how cancer starts in the first place and the mechanisms by which it grows and spreads. Cancer is the No. 2 killer in the U.S. It has replaced heart disease as the No. 1 cause of death in 21 states and it will kill nearly 600,000 people this year, the American Cancer Society says. About 1.68 million Americans will be diagnosed with some form of cancer this year. President Barack Obama launched the "moonshot" initiative in February, asking for close to $1 billion in extra spending over the next two years.
Labels:
Cancer,
cancer research,
cancer treatment
Location:
Houston, TX, USA
Tuesday, May 5, 2015
Researchers predict 50% more women diagnosed with breast cancer by 2030
BY SHAY ARTHUR
Researchers with the National Cancer Institute said by 2030 the number of women diagnosed with breast cancer will increase by 50%.
“Regardless whether you have a history or not it’s still devastating, you know you think about so many things, your children, my husband, being a mother and wife,” explained Tracey Dillihunt Monday afternoon.
Dillihunt said she knows firsthand the effects of breast cancer.
Not only was she a six-year survivor, her two sisters were also diagnosed before her.
While breast cancer has been part of Dillihunt’s life for years, she was still surprised to hear cases were predicted to increase by 50% in the next 15 years.
But breast cancer researcher Dr. Gregory Vidal of the West Cancer Center said the study was pretty on point with the trends he’s been seeing.
“We sort of expected those numbers to come up,” explained Vidal.
Vidal cited a few reasons for the increase including longer life expectancy and more screening that allowed doctors to catch very early stage growths that down the road might not require treatment.
Dr. Vidal, who has dedicated his life to research, said he didn’t want the numbers to scare people.
“Anything that brings attention to it is a plus in my book. What I don’t want to happen is for people to overreact by seeing the numbers,” he said.
Vidal explained a big part of the increase in the study comes from doctors detecting stage 0 breast cancer or abnormal cells.
“Some people wouldn’t even consider it breast cancer,” he said.
Vidal also pointed out the study predicted the number of aggressive breast cancer tumors will drop by 10%, which was good news.
“Those tumors tend to affect younger women and those tumors tend to take your life,” explained Vidal.
Studies showed one in eight women were predicted to have breast cancer.
Dillihunt said she hoped the study would bring awareness and help the millions of people affected by breast cancer.
“If you don’t have breast cancer, you’re going to know someone that has it,” she said.
Researchers with the National Cancer Institute said by 2030 the number of women diagnosed with breast cancer will increase by 50%.
“Regardless whether you have a history or not it’s still devastating, you know you think about so many things, your children, my husband, being a mother and wife,” explained Tracey Dillihunt Monday afternoon.
Dillihunt said she knows firsthand the effects of breast cancer.
Not only was she a six-year survivor, her two sisters were also diagnosed before her.
While breast cancer has been part of Dillihunt’s life for years, she was still surprised to hear cases were predicted to increase by 50% in the next 15 years.
But breast cancer researcher Dr. Gregory Vidal of the West Cancer Center said the study was pretty on point with the trends he’s been seeing.
“We sort of expected those numbers to come up,” explained Vidal.
Vidal cited a few reasons for the increase including longer life expectancy and more screening that allowed doctors to catch very early stage growths that down the road might not require treatment.
Dr. Vidal, who has dedicated his life to research, said he didn’t want the numbers to scare people.
“Anything that brings attention to it is a plus in my book. What I don’t want to happen is for people to overreact by seeing the numbers,” he said.
Vidal explained a big part of the increase in the study comes from doctors detecting stage 0 breast cancer or abnormal cells.
“Some people wouldn’t even consider it breast cancer,” he said.
Vidal also pointed out the study predicted the number of aggressive breast cancer tumors will drop by 10%, which was good news.
“Those tumors tend to affect younger women and those tumors tend to take your life,” explained Vidal.
Studies showed one in eight women were predicted to have breast cancer.
Dillihunt said she hoped the study would bring awareness and help the millions of people affected by breast cancer.
“If you don’t have breast cancer, you’re going to know someone that has it,” she said.
Subscribe to:
Posts (Atom)


